Endothelial dysfunction Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2003	Assessment of endothelial damage and dysfunction: observations in relation to heart failure.	+	-	nl	QJM 96(4):253-67 (2003)
2	2006	Recent advances in understanding endothelial dysfunction in atherosclerosis.	+	-	nl	Clin Med Res 4(1):53-65 (2006)
3	2007	Endothelial dysfunction in insulin resistance and type 2 diabetes.	+	-	nl	J Intern Med 262(2):173-83 (2007)
4	2000	Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.	+	-	nl	Clin Invest Med 23(2):144-61 (2000)
5	2004	Physiology of the endothelium.	+	-	nl	Br J Anaesth 93(1):105-13 (2004)
6	1993	Integration of factors controlling vascular tone. Overview.	+	-	nl	Anesthesiology 79(6):1368-80 (1993)
7	2003	Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?	+	-	nl	Crit Care 7(2):130-8 (2003)
8	1992	Endothelial vasomotor regulation in health and disease.	+	-	nl	Can J Anaesth 39(8):838-57 (1992) Searle NR
9	2005	Childhood origins of endothelial dysfunction.	+	-	nl	Heart 91(10):1272-4 (2005)
10	2005	Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques.	+	-	nl	Heart 91(4):553-8 (2005)
11	1997	Non-invasive assessment of endothelial function.	+	-	nl	Heart 77(4):297-8 (1997)
12	1994	Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.	+	-	nl	Br Heart J 72(3 Suppl):S11-4 (1994)
13	1991	St Cyres lecture. Endothelium in control.	+	-	nl	Br Heart J 65(3):116-25 (1991)
14	2000	Endothelial vasomotor dysfunction in hypertension.	+	-	nl	J Hum Hypertens 14(8):481-3 (2000)
15	2000	Endothelial dysfunction in arterial hypertension.	+	-	nl	J Hum Hypertens 14 Suppl 1(-):S20-5 (2000)
16	1997	Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure.	+	-	nl	J Hum Hypertens 11(1):45-9 (1997)
17	2010	Novel mechanisms of endothelial dysfunction in diabetes.	+	-	nl	J Cardiovasc Dis Res 1(2):59-63 (2010)
18	2008	In search of understanding the endothelium.	+	-	nl	Cardiol J 15(4):229-32 (2008)
19	2008	Endothelial effects of antihypertensive treatment: focus on irbesartan.	+	-	nl	Vasc Health Risk Manag 4(1):89-101 (2008)
20	2008	Mechanisms of endothelial dysfunction in obstructive sleep apnea.	+	-	nl	Vasc Health Risk Manag 4(6):1327-35 (2008)
21	2007	Endothelial dysfunction in diabetes mellitus.	+	-	nl	Vasc Health Risk Manag 3(6):853-76 (2007)
22	2005	Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.	+	-	nl	Vasc Health Risk Manag 1(3):183-98 (2005) Hadi HA
23	2005	Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.	+	-	nl	Vasc Health Risk Manag 1(1):55-71 (2005) Ding H
24	2005	Corticosteroids and endothelial dysfunction.	+	-	nl	Vasc Health Risk Manag 1(4):261-2 (2005)
25	2003	Molecular basis of endothelial dysfunction in sepsis.	+	-	nl	Cardiovasc Res 60(1):49-57 (2003)
26	1999	Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia.	+	-	nl	Cardiovasc Res 44(3):474-6 (1999)
27	1999	Homocysteine and endothelial function.	+	-	nl	Cardiovasc Res 42(3):578-82 (1999)
28	1997	Endothelial dysfunction and pathogenesis of diabetic angiopathy.	+	-	nl	Cardiovasc Res 34(1):55-68 (1997)
29	2009	Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?	+	-	nl	Br J Pharmacol 156(4):545-62 (2009)
30	2000	Endothelial dysfunction in diabetes.	+	-	nl	Br J Pharmacol 130(5):963-74 (2000)
31	2001	Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: a role for Rho/Rho kinase.	+	-	nl	Cell Microbiol 3(10):649-58 (2001)
32	2007	Oxidative stress and endothelial dysfunction.	+	-	nl	Hamostaseologie 27(1):5-12 (2007)
33	2006	von Willebrand factor, endothelial dysfunction, and cardiovascular disease.	+	-	nl	J Thromb Haemost 4(6):1186-93 (2006)
34	2001	Oxidant stress and endothelial cell dysfunction.	+	-	nl	Am J Physiol Cell Physiol 280(4):C719-41 (2001)
35	2006	Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).	+	-	nl	Am J Physiol Heart Circ Physiol 291(3):H985-1002 (2006)
36	2001	Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?	+	-	nl	Am J Physiol Heart Circ Physiol 281(3):H981-6 (2001)
37	2001	Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?	+	-	nl	Am J Physiol Heart Circ Physiol 280(6):H2484-8 (2001)
38	2005	Endothelial cell dysfunction: can't live with it, how to live without it.	+	-	nl	Am J Physiol Renal Physiol 288(5):F871-80 (2005)
39	2006	Endothelial dysfunction: a comprehensive appraisal.	+	-	nl	Cardiovasc Diabetol 5(-):4 (2006)
40	2009	Endothelial dysfunction: the first step toward coronary arteriosclerosis.	+	-	nl	Circ J 73(4):595-601 (2009)
41	2007	Endothelial function and dysfunction: testing and clinical relevance.	+	-	nl	Circulation 115(10):1285-95 (2007)
42	2003	Endothelial dysfunction.	+	-	nl	Circulation 108(17):2060-1 (2003) Willerson JT
43	2003	Endothelial function testing as a biomarker of vascular disease.	+	-	nl	Circulation 108(17):2054-9 (2003)
44	2001	Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.	+	-	nl	Diabetes Metab 27(4 Pt 1):436-47 (2001)
45	2001	Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.	+	-	nl	Diabetes Metab 27(4 Pt 1):425-34 (2001)
46	2008	One step beyond: glutathione peroxidase and endothelial dysfunction.	+	-	nl	Hypertension 51(4):825-6 (2008)
47	2008	Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation.	+	-	nl	Hypertension 51(1):31-2 (2008)
48	2007	Methods for evaluating endothelial function in humans.	+	-	nl	Hypertension 49(4):748-60 (2007)
49	2004	Endothelial dysfunction.	+	-	nl	J Am Soc Nephrol 15(8):1983-92 (2004)
50	2003	The clinical implications of endothelial dysfunction.	+	-	nl	J Am Coll Cardiol 42(7):1149-60 (2003)
51	1999	Assessment and treatment of endothelial dysfunction in humans.	+	-	nl	J Am Coll Cardiol 34(3):631-8 (1999)
52	1997	Endothelial dysfunction: does it matter? Is it reversible?	+	-	nl	J Am Coll Cardiol 30(2):325-33 (1997)
53	2009	Vascular actions of insulin with implications for endothelial dysfunction.	+	-	nl	Am J Physiol Endocrinol Metab 297(3):E568-77 (2009)
54	2010	Endothelial dysfunction and hypertension: cause or effect?	+	-	nl	Hypertension 55(5):1092-4 (2010)
55	2010	Arterial stiffness and endothelial function: key players in vascular health.	+	-	nl	Hypertension 55(3):612-3 (2010)
56	2005	Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension.	+	-	nl	Hypertension 46(1):29-30 (2005) Johnson FK
57	2006	Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.	+	-	nl	J Am Soc Nephrol 17(4 Suppl 2):S61-3 (2006)
58	2007	A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.	+	-	nl	Nephrol Dial Transplant 22(10):2775-7 (2007)
59	2004	Role of endothelial dysfunction in atherosclerosis.	+	-	nl	Circulation 109(23 Suppl 1):III27-32 (2004)
60	2004	Endothelial dysfunction in pulmonary hypertension.	+	-	nl	Circulation 109(2):159-65 (2004)
61	2003	Clinical utility of endothelial function testing: ready for prime time?	+	-	nl	Circulation 107(25):3243-7 (2003)
62	2005	Childhood infection and endothelial dysfunction: a potential link in atherosclerosis?	+	-	nl	Circulation 111(13):1568-70 (2005) Napoli C
63	2009	Molecular insights and therapeutic targets for diabetic endothelial dysfunction.	+	-	nl	Circulation 120(13):1266-86 (2009)
64	2003	Endothelial dysfunction: a marker of atherosclerotic risk.	+	-	nl	Arterioscler Thromb Vasc Biol 23(2):168-75 (2003)
65	2004	Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.	+	-	nl	Cell Death Differ 11 Suppl 1():S56-64 (2004) Austin RC
66	2006	Arterial endothelium and atherothrombogenesis II--the role of endothelial dysfunction in atherothrombotic lesions.	+	-	nl	Rev Port Cardiol 25(12):1159-86 (2006)
67	2010	From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.	+	-	nl	Rev Port Cardiol 29(5):801-24 (2010)
68	2009	Endothelial function and atherosclerosis: circulatory markers with clinical usefulness.	+	-	nl	Rev Port Cardiol 28(10):1121-51 (2009)
69	2008	An integrated view of insulin resistance and endothelial dysfunction.	+	-	nl	Endocrinol Metab Clin North Am 37(3):685-711, ix-x (2008)
70	2007	Cardiovascular actions of insulin.	+	-	nl	Endocr Rev 28(5):463-91 (2007)
71	2002	Back to the salt mines-- endothelial dysfunction in hypertension and compensatory role of endothelium-derived hyperpolarizing factor (EDHF).	+	-	nl	J Physiol 543(Pt 1):1 (2002)
72	2003	New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation.	+	-	nl	J Pharmacol Sci 93(4):399-404 (2003)
73	2003	New methods to evaluate endothelial function: Non-invasive method of evaluating endothelial function in humans.	+	-	nl	J Pharmacol Sci 93(4):405-8 (2003)
74	2003	New methods to evaluate endothelial function: Evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopy.	+	-	nl	J Pharmacol Sci 93(4):417-22 (2003)
75	2009	Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD.	+	-	nl	J Pharmacol Sci 109(1):14-9 (2009)
76	2009	Endothelium-dependent contractions and endothelial dysfunction in human hypertension.	+	-	nl	Br J Pharmacol 157(4):527-36 (2009)
77	2011	Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis.	+	-	nl	PLoS One 6(3):e16974 (2011)
78	2011	Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.	+	-	nl	Antioxid Redox Signal 15(4):933-48 (2011)
79	2008	Oxidative stress impairs endothelial progenitor cell function.	+	-	nl	Antioxid Redox Signal 10(11):1895-907 (2008)
80	2005	Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.	+	-	nl	Antioxid Redox Signal 7(11-12):1568-80 (2005)
81	2003	Endothelial dysfunction in preeclampsia and eclampsia: current etiology and future non-invasive assessment.	+	-	nl	Isr Med Assoc J 5(10):724-6 (2003)
82	2003	Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?	+	-	nl	Isr Med Assoc J 5(10):736-8 (2003) Shechter M
83	2006	Endothelial dysfunction in pre-eclampsia.	+	-	nl	Pharmacol Rep 58 Suppl(-):69-74 (2006)
84	2006	Clinical aspects of assessment of endothelial function.	+	-	nl	Pharmacol Rep 58 Suppl(-):33-40 (2006)
85	2008	Endothelium in health and disease.	+	-	nl	Pharmacol Rep 60(1):139-43 (2008)
86	2008	Endothelial dysfunction in heart failure.	+	-	nl	Pharmacol Rep 60(1):119-26 (2008)
87	2008	NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype.	+	-	nl	Pharmacol Rep 60(1):21-8 (2008)
88	2011	Variant angina associated with coronary artery endothelial dysfunction and myocardial bridge: a case report and review of the literature.	+	-	nl	Intern Med 50(21):2601-6 (2011)
89	2005	Endothelial function and coronary spastic angina.	+	-	nl	Intern Med 44(2):91-9 (2005)
90	2009	Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction.	+	-	nl	Can J Cardiol 25 Suppl A(-):15A-20A (2009)
91	2009	Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.	+	-	nl	Vasc Health Risk Manag 5(1):265-72 (2009)
92	2009	Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil.	+	-	nl	Vasc Health Risk Manag 5(1):301-14 (2009)
93	2007	Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.	+	-	nl	Vasc Health Risk Manag 3(1):1-9 (2007)
94	2008	Measurement of endothelial function and its clinical utility for cardiovascular risk.	+	-	nl	Vasc Health Risk Manag 4(3):647-52 (2008)
95	2009	Human endothelial function and microvascular ageing.	+	-	nl	Exp Physiol 94(3):311-6 (2009)
96	2010	Physical exercise and endothelial dysfunction.	+	-	nl	Arq Bras Cardiol 95(5):e130-7 (2010)
97	2010	Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.	+	-	nl	Mediators Inflamm 2010(-):792393 (2010)
98	2009	Vascular consequences of dietary salt intake.	+	-	nl	Am J Physiol Renal Physiol 297(2):F237-43 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.